Thompson Davis & Co., Inc. Icad Inc Transaction History
Thompson Davis & Co., Inc.
- $124 Million
- Q1 2025
A detailed history of Thompson Davis & Co., Inc. transactions in Icad Inc stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 45,554 shares of ICAD stock, worth $176,293. This represents 0.07% of its overall portfolio holdings.
Number of Shares
45,554
Previous 16,777
171.53%
Holding current value
$176,293
Previous $30,000
210.0%
% of portfolio
0.07%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ICAD
# of Institutions
64Shares Held
7.93MCall Options Held
67KPut Options Held
40.2K-
Vanguard Group Inc Valley Forge, PA1.21MShares$4.68 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY919KShares$3.56 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT782KShares$3.03 Million0.21% of portfolio
-
First Eagle Investment Management, LLC725KShares$2.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny656KShares$2.54 Million0.0% of portfolio
About ICAD INC
- Ticker ICAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,333,900
- Market Cap $98M
- Description
- iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...